Skip to main content
. 2016 Oct 15;7(50):82493–82503. doi: 10.18632/oncotarget.12696

Table 1. Comparison of biomarkers examined in this study of colon cancer patients.

Anti-FIRs antibodies Anti-p53 antibodies CEA CA19-9
sensitivity(%) 78 30 78 62
specificity(%) 78 91 78 62
Positive Predictive Value(%) 87 87 88 77
Negative Predictive Value(%) 63 40 63 44